GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (HKSE:02607) » Definitions » Additional Paid-In Capital

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Additional Paid-In Capital : HK$0 Mil(As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Additional Paid-In Capital?


Shanghai Pharmaceuticals Holding Co's quarterly additional paid-in capital increased from Sep. 2023 (HK$0 Mil) to Dec. 2023 (HK$32,230 Mil) but then stayed the same from Dec. 2023 (HK$32,230 Mil) to Mar. 2024 (HK$0 Mil).

Shanghai Pharmaceuticals Holding Co's annual additional paid-in capital increased from Dec. 2021 (HK$20,025 Mil) to Dec. 2022 (HK$32,755 Mil) but then declined from Dec. 2022 (HK$32,755 Mil) to Dec. 2023 (HK$32,230 Mil).


Shanghai Pharmaceuticals Holding Co Additional Paid-In Capital Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Additional Paid-In Capital Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18,154.50 19,329.85 20,024.62 32,755.13 32,229.73

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 32,206.75 - 32,229.73 -

Shanghai Pharmaceuticals Holding Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Shanghai Pharmaceuticals Holding Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pharmaceuticals Holding Co (HKSE:02607) Business Description

Traded in Other Exchanges
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.
Executives
Blackrock, Inc. 2201 Interest of corporation controlled by you
Shanghai Industrial Investment (holdings) Company Limited 2201 Interest of corporation controlled by you
Siic International Investment Company Limited 2101 Beneficial owner
Citigroup Inc. 2201 Interest of corporation controlled by you
Lsv Asset Management 2102 Investment manager

Shanghai Pharmaceuticals Holding Co (HKSE:02607) Headlines

No Headlines